Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
Helping Clients Improve their Biomanufacturing Processes
MilliporeSigma's BioReliance® End-to-End Biodevelopment Center Up and Running
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
Epigenetics Revitalizes Drug Discovery
Surging Knowledge of Epigenetic Mechanisms May Sweep Epigenetic Drugs
For full access to this article login to GEN Select now.
Biobank Diversity Facilitates Drug & Diagnostic Development
- The biobanking market, estimated at $7.88 billion by Visiongain, is poised to expand as researchers continue to migrate toward the use of human tissues and biomaterials for primary research, and pharmaceutical and diagnostic-tool development. A large and difficult-to-estimate number of facilities, ranging from individual research laboratories to hospitals, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.